Catalyst Pharmaceuticals, Inc.

CPRX · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$689,892$652,800$580,656$517,553
Short-Term Investments$0$0$0$0
Receivables$106,769$66,313$72,258$65,487
Inventory$28,029$18,650$19,778$19,541
Other Curr. Assets$27,763$20,976$13,026$21,028
Total Curr. Assets$852,453$758,739$685,718$623,609
Property Plant & Equip (Net)$3,087$3,233$3,397$3,584
Goodwill$0$0$0$0
Intangibles$128,639$137,983$147,327$156,672
Long-Term Investments$19,167$21,256$24,208$21,564
Tax Assets$48,256$50,704$48,222$45,982
Other NC Assets$0$0$0$0
Total NC Assets$199,149$213,176$223,154$227,802
Other Assets$0$0$0$0
Total Assets$1,051,602$971,915$908,872$851,411
Liabilities
Payables$9,096$5,528$11,197$16,593
Short-Term Debt$428$419$410$402
Tax Payable$0$439$11,087$894
Deferred Revenue$0$0$0$0
Other Curr. Liab.$119,211$106,621$88,955$102,789
Total Curr. Liab.$128,735$113,007$111,649$120,678
LT Debt$2,461$2,572$2,681$2,786
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$161$309$259$315
Total NC Liab.$2,622$2,881$2,940$3,101
Other Liabilities$0$0$0$0
Cap. Leases$2,461$2,991$3,091$3,188
Total Liabilities$131,357$115,888$114,589$123,779
Equity
Pref Stock$0$0$0$0
Common Stock$123$122$122$121
Retained Earnings$446,789$394,006$341,898$285,161
AOCI$0$31-$17$64
Other Equity$473,333$461,868$452,280$442,286
Total Equity$920,245$856,027$794,283$727,632
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$1,051,602$971,915$908,872$851,411
Net Debt-$687,003-$649,809-$577,565-$514,365
Catalyst Pharmaceuticals, Inc. (CPRX) Financial Statements & Key Stats | AlphaPilot